Advances in Synthetic Biology and Biosafety Governance

被引:36
|
作者
Li, Jing [1 ]
Zhao, Huimiao [2 ]
Zheng, Lanxin [1 ]
An, Wenlin [1 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing, Peoples R China
[2] Beijing Univ Chem Technol, Coll Humanities & Law, Beijing, Peoples R China
关键词
synthetic biology; artificial life; biosafety; regulation and legislation; public health emergency response system; pandemic control strategies; ESCHERICHIA-COLI; MICROBIAL-PRODUCTION; EUROPEAN-UNION; E; COLI; EXPRESSION; ACID; CYBERBIOSECURITY; CONVERSION; GENOME; CRISPR;
D O I
10.3389/fbioe.2021.598087
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Tremendous advances in the field of synthetic biology have been witnessed in multiple areas including life sciences, industrial development, and environmental bio-remediation. However, due to the limitations of human understanding in the code of life, any possible intended or unintended uses of synthetic biology, and other unknown reasons, the development and application of this technology has raised concerns over biosafety, biosecurity, and even cyberbiosecurity that they may expose public health and the environment to unknown hazards. Over the past decades, some countries in Europe, America, and Asia have enacted laws and regulations to control the application of synthetic biology techniques in basic and applied research and this has resulted in some benefits. The outbreak of the COVID-19 caused by novel coronavirus SARS-CoV-2 and various speculations about the origin of this virus have attracted more attention on bio-risk concerns of synthetic biology because of its potential power and uncertainty in the synthesis and engineering of living organisms. Therefore, it is crucial to scrutinize the control measures put in place to ensure appropriate use, promote the development of synthetic biology, and strengthen the governance of pathogen-related research, although the true origin of coronavirus remains hotly debated and unresolved. This article reviews the recent progress made in the field of synthetic biology and combs laws and regulations in governing bio-risk issues. We emphasize the urgent need for legislative and regulatory constraints and oversight to address the biological risks of synthetic biology.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] SYNTHETIC BIOLOGY AND BIOSAFETY GOVERNANCE IN THE EUROPEAN UNION AND THE UNITED STATES
    Akpoviri, Frank
    Zainol, Zinatul Ashiqin
    Baharum, Syarul Nataqain
    IIUM LAW JOURNAL, 2020, 28 (01): : 37 - 71
  • [2] Building-in biosafety for synthetic biology
    Wright, Oliver
    Stan, Guy-Bart
    Ellis, Tom
    MICROBIOLOGY-SGM, 2013, 159 : 1221 - 1235
  • [3] Biosafety and biosecurity in Synthetic Biology: A review
    Gomez-Tatay, Lucia
    Hernandez-Andreu, Jose M.
    CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY, 2019, 49 (17) : 1587 - 1621
  • [4] SYNTHETIC BIOLOGY MODERN CHALLENGES AND PROBLEMS OF BIOSAFETY
    Zavriev, Sergei K.
    Shemyakin, Igor G.
    MIROVAYA EKONOMIKA I MEZHDUNARODNYE OTNOSHENIYA, 2019, 63 (12): : 77 - 83
  • [5] Bottlenecks and opportunities for synthetic biology biosafety standards
    Pei, Lei
    Garfinkel, Michele
    Schmidt, Markus
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [6] Bottlenecks and opportunities for synthetic biology biosafety standards
    Lei Pei
    Michele Garfinkel
    Markus Schmidt
    Nature Communications, 13
  • [7] Advances in synthetic biology
    Wang, Shue
    SLAS TECHNOLOGY, 2024, 29 (05):
  • [8] Synthetic biology, security and governance
    Filippa Lentzos
    BioSocieties, 2012, 7 : 339 - 351
  • [9] Adaptive governance of synthetic biology
    Tait, Joyce
    EMBO REPORTS, 2012, 13 (07) : 579 - 579
  • [10] Synthetic biology, security and governance
    Lentzos, Filippa
    BIOSOCIETIES, 2012, 7 (04) : 339 - 351